PLUR Pluri Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: PLUR

Price (delayed)

$5.05

Market cap

$26.18M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$4.64

Enterprise value

$50.8M

Pluristem Therapeutics Inc. is a leading regenerative medicine company developing novel placenta-based cell therapy product candidates. The Company has reported robust clinical trial data in multiple indications for its patented ...

Highlights
Pluri's EPS has increased by 43% YoY and by 17% QoQ
The gross profit has grown by 42% from the previous quarter and by 8% YoY
The equity has plunged by 81% YoY and by 51% from the previous quarter
The quick ratio has contracted by 25% YoY and by 13% from the previous quarter
Sector: Healthcare
Industry: Biotechnology
Website: http://www.pluristem.com
Peers: NWBO

Key stats

What are the main financial stats of PLUR
Market
Shares outstanding
5.19M
Market cap
$26.18M
Enterprise value
$50.8M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
5.95
Price to sales (P/S)
73.43
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
142.3
Earnings
Revenue
$357,000
EBIT
-$22.28M
EBITDA
-$21.99M
Free cash flow
-$18.82M
Per share
EPS
-$4.64
Free cash flow per share
-$3.63
Book value per share
$0.85
Revenue per share
$0.07
TBVPS
$8.01
Balance sheet
Total assets
$41.56M
Total liabilities
$34.95M
Debt
$30.46M
Equity
$4.4M
Working capital
$27.72M
Liquidity
Debt to equity
6.92
Current ratio
7.12
Quick ratio
6.84
Net debt/EBITDA
-1.12
Margins
EBITDA margin
-6,159.1%
Gross margin
97.5%
Net margin
-6,708.4%
Operating margin
-6,788.2%
Efficiency
Return on assets
-49.6%
Return on equity
-209.5%
Return on invested capital
-32.8%
Return on capital employed
-60.2%
Return on sales
-6,242%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

PLUR stock price

How has the Pluri stock price performed over time
Intraday
-2.32%
1 week
-11.56%
1 month
434.39%
1 year
435.81%
YTD
772.04%
QTD
528.89%

Financial performance

How have Pluri's revenue and profit performed over time
Revenue
$357,000
Gross profit
$348,000
Operating income
-$24.23M
Net income
-$23.95M
Gross margin
97.5%
Net margin
-6,708.4%
The gross profit has grown by 42% from the previous quarter and by 8% YoY
Pluri's revenue has increased by 41% from the previous quarter and by 11% YoY
PLUR's net margin is up by 37% since the previous quarter and by 35% year-on-year
Pluri's operating margin has increased by 33% YoY and by 33% QoQ

Growth

What is Pluri's growth rate over time

Valuation

What is Pluri stock price valuation
P/E
N/A
P/B
5.95
P/S
73.43
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
142.3
Pluri's EPS has increased by 43% YoY and by 17% QoQ
PLUR's price to book (P/B) is 105% higher than its 5-year quarterly average of 2.9 and 86% higher than its last 4 quarters average of 3.2
The equity has plunged by 81% YoY and by 51% from the previous quarter
Pluri's revenue has increased by 41% from the previous quarter and by 11% YoY
PLUR's P/S is 41% below its last 4 quarters average of 124.7

Efficiency

How efficient is Pluri business performance
Pluri's return on equity has shrunk by 83% YoY and by 24% QoQ
Pluri's return on sales has increased by 40% YoY and by 38% QoQ
PLUR's return on invested capital is up by 25% year-on-year and by 8% since the previous quarter
Pluri's return on assets has increased by 3.5% QoQ

Dividends

What is PLUR's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for PLUR.

Financial health

How did Pluri financials performed over time
The company's total assets is 19% higher than its total liabilities
The company's total assets fell by 31% YoY and by 7% QoQ
The current ratio has declined by 25% year-on-year and by 13% since the previous quarter
The debt to equity has surged by 110% since the previous quarter
The equity has plunged by 81% YoY and by 51% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.